{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T18:10:27Z","timestamp":1730916627760,"version":"3.28.0"},"reference-count":21,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Neurol"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Driving the overdose epidemic, a significant proportion of adult and adolescent patients seen in neurology practice and hospital settings has substance use disorder. Fortunately, there are effective treatments available, in particular for opioid addiction. Some elements of treatment can be delivered directly in medical office-based settings, while others are best provided from within specialized addiction treatment facilities. In this article, we review the nature of substance use disorders, and the various treatment approaches that can be utilized to stabilize patients and facilitate their building a strong recovery foundation. Some interventions discussed may be directly provided by a physician identifying the disorder, while others involve collaboration with specialized addiction treatment centers and recovery support entities.<\/jats:p>","DOI":"10.1055\/s-0044-1787654","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T23:12:25Z","timestamp":1718752345000},"page":"471-479","source":"Crossref","is-referenced-by-count":0,"title":["Substance Use Disorder Treatment: Opportunities for Interdisciplinary Collaboration in Neurology and Beyond"],"prefix":"10.1055","volume":"44","author":[{"given":"Kenneth B.","family":"Stoller","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,6,18]]},"reference":[{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/add.12269","article-title":"Managing psychiatric comorbidity within versus outside of methadone treatment settings: a randomized and controlled evaluation","volume":"108","author":"R K Brooner","year":"2013","journal-title":"Addiction"},{"issue":"08","key":"ref3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/070674370805300804","article-title":"Assessment and management of chronic pain in individuals seeking treatment for opioid dependence disorder","volume":"53","author":"M R Clark","year":"2008","journal-title":"Can J Psychiatry"},{"issue":"09","key":"ref4","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/pme.12430","article-title":"Severity and interference of chronic pain in methadone-maintained outpatients","volume":"15","author":"K E Dunn","year":"2014","journal-title":"Pain Med"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"09","DOI":"10.35946\/arcr.v41.1.09","article-title":"Recovery-oriented systems of care: a perspective on the past, present, and future","volume":"41","author":"L Davidson","year":"2021","journal-title":"Alcohol Res"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jsat.2004.07.005","article-title":"Behavioral contingencies improve counseling attendance in an adaptive treatment model","volume":"27","author":"R K Brooner","year":"2004","journal-title":"J Subst Abuse Treat"},{"issue":"S 02","key":"ref11","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.drugalcdep.2006.12.006","article-title":"Comparing adaptive stepped care and monetary-based voucher interventions for opioid dependence","volume":"88","author":"R K Brooner","year":"2007","journal-title":"Drug Alcohol Depend"},{"volume-title":"Federal Guidelines for Opioid Treatment Programs. HHS Publication No. (SMA) XX\u2013XXXX","year":"2015","author":"SAMHSA (Substance Abuse and Mental Health Services Administration)","key":"ref12"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/ADM.0000000000000810","article-title":"Peer recovery support services across the continuum: in community, hospital, corrections, and treatment and recovery agency settings - a narrative review","volume":"16","author":"E Stack","year":"2022","journal-title":"J Addict Med"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12888-019-2098-3","article-title":"Prediction of psychiatric comorbidity on premature death in a cohort of patients with substance use disorders: a 42-year follow-up","volume":"19","author":"M Fridell","year":"2019","journal-title":"BMC Psychiatry"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/02791072.2012.718643","article-title":"Integrating substance use disorder services with primary care: the experience in California","volume":"44","author":"H Padwa","year":"2012","journal-title":"J Psychoactive Drugs"},{"issue":"05","key":"ref16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s11904-023-00667-9","article-title":"Integrated care models: HIV and substance use","volume":"20","author":"K Hill","year":"2023","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"08","key":"ref17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1089\/apc.2006.0192","article-title":"Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy","volume":"21","author":"G M Lucas","year":"2007","journal-title":"AIDS Patient Care STDS"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamapsychiatry.2014.2421","article-title":"The untapped potential of office-based buprenorphine treatment","volume":"72","author":"S C Sigmon","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/cid\/ciab578","article-title":"The effect of buprenorphine on human immunodeficiency virus viral suppression","volume":"73","author":"J Kim","year":"2021","journal-title":"Clin Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"104191","DOI":"10.1016\/j.drugpo.2023.104191","article-title":"Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomes","volume":"121","author":"O Falade-Nwulia","year":"2023","journal-title":"Int J Drug Policy"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/08897077.2013.819828","article-title":"A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment","volume":"35","author":"M I Fingerhood","year":"2014","journal-title":"Subst Abus"},{"issue":"03","key":"ref24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/ajad.13268","article-title":"Buprenorphine treatment retention and comorbidities among patients with opioid use disorder in a primary care setting","volume":"31","author":"M M Sweeney","year":"2022","journal-title":"Am J Addict"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"103786","DOI":"10.1016\/j.drugpo.2022.103786","article-title":"Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019\"","volume":"110","author":"N Krawczyk","year":"2022","journal-title":"Int J Drug Policy"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"109089","DOI":"10.1016\/j.drugalcdep.2021.109089","article-title":"Buprenorphine prescriber monthly patient caseloads: an examination of 6-year trajectories","volume":"228","author":"I Cabreros","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"S 01","key":"ref27","doi-asserted-by":"crossref","first-page":"A63","DOI":"10.1186\/1940-0640-10-S1-A63","article-title":"A collaborative opioid prescribing (CoOP) model linking opioid treatment programs with office-based buprenorphine providers","volume":"10","author":"K B Stoller","year":"2015","journal-title":"Addict Sci Clin Pract"},{"issue":"04","key":"ref29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ADM.0000000000000310","article-title":"Vermont hub-and-spoke model of care for opioid use disorder: development, implementation, and impact","volume":"11","author":"J R Brooklyn","year":"2017","journal-title":"J Addict Med"}],"container-title":["Seminars in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1787654.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T14:51:08Z","timestamp":1730818268000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1787654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":21,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2024,7,16]]},"published-print":{"date-parts":[[2024,8]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1787654","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0271-8235","1098-9021"],"issn-type":[{"type":"print","value":"0271-8235"},{"type":"electronic","value":"1098-9021"}],"subject":[],"published":{"date-parts":[[2024,6,18]]}}}